72F fusion protein

Overview
72F fusion protein is a candidate tuberculosis vaccine created by SSI. The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.

Related Chapters

 * Fusion protein